Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Brettschneider

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Current Pharmaceutical Design|May 23, 2012
Biochemical markers of autoimmune diseases of the nervous systemHayrettin Tumani, Johannes Brettschneider
The Cochrane Database of Systematic Reviews|June 7, 2013
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseJohannes Brettschneider, Jerome Kurent, Albert Ludolph
Current Opinion in Neurology|August 25, 2012
Amyotrophic lateral sclerosisAlbert C Ludolph, Johannes Brettschneider, Jochen H Weishaupt
Journal of Neurology|March 10, 2009
Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?Johannes Brettschneider, Axel Petzold, Sigurd Süssmuth, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 11, 2012
Slowly progressive Foix-Chavany-Marie syndrome as a precursor of a primary progressive aphasiaIngo Uttner, Johannes Brettschneider, Alexander Unrath, et al.
The Cochrane Database of Systematic Reviews|July 23, 2008
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseJohannes Brettschneider, Jerome Kurent, Albert Ludolph, et al.
Cerebellum (London, England)|October 22, 2008
Cognitive impairment in superficial siderosis of the central nervous system: a case reportIngo Uttner, Hayrettin Tumani, Christine von Arnim, et al.
Neuroscience Letters|July 4, 2006
Erythropoietin in the cerebrospinal fluid in neurodegenerative diseasesJohannes Brettschneider, Karin Widl, Hannelore Ehrenreich, et al.
Muscle & Nerve|July 22, 2008
Intracerebral hemorrhage in a patient with glycogenosis type II (Pompe disease): is there a pathophysiological relationship?Johannes Brettschneider, Anne-D Sperfeld, Albert C Ludolph, et al.
Expert Review of Proteomics|February 4, 2010
2D DIGE of the cerebrospinal fluid proteome in neurological diseasesHayrettin Tumani, Vera Lehmensiek, Stefan Lehnert, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|May 23, 2012
Biochemical markers of autoimmune diseases of the nervous systemHayrettin Tumani, Johannes Brettschneider
The Cochrane Database of Systematic Reviews|June 7, 2013
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseJohannes Brettschneider, Jerome Kurent, Albert Ludolph
Current Opinion in Neurology|August 25, 2012
Amyotrophic lateral sclerosisAlbert C Ludolph, Johannes Brettschneider, Jochen H Weishaupt
Journal of Neurology|March 10, 2009
Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?Johannes Brettschneider, Axel Petzold, Sigurd Süssmuth, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 11, 2012
Slowly progressive Foix-Chavany-Marie syndrome as a precursor of a primary progressive aphasiaIngo Uttner, Johannes Brettschneider, Alexander Unrath, et al.
The Cochrane Database of Systematic Reviews|July 23, 2008
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseJohannes Brettschneider, Jerome Kurent, Albert Ludolph, et al.
Cerebellum (London, England)|October 22, 2008
Cognitive impairment in superficial siderosis of the central nervous system: a case reportIngo Uttner, Hayrettin Tumani, Christine von Arnim, et al.
Neuroscience Letters|July 4, 2006
Erythropoietin in the cerebrospinal fluid in neurodegenerative diseasesJohannes Brettschneider, Karin Widl, Hannelore Ehrenreich, et al.
Muscle & Nerve|July 22, 2008
Intracerebral hemorrhage in a patient with glycogenosis type II (Pompe disease): is there a pathophysiological relationship?Johannes Brettschneider, Anne-D Sperfeld, Albert C Ludolph, et al.
Expert Review of Proteomics|February 4, 2010
2D DIGE of the cerebrospinal fluid proteome in neurological diseasesHayrettin Tumani, Vera Lehmensiek, Stefan Lehnert, et al.
Pageof 7